RankingsPricing
  1. US-listed companies
  2. CATALYST PHARMACEUTICALS, INC.
  3. Financials
  4. Retained earnings

CATALYST PHARMACEUTICALS, INC.CPRX

Market cap
$2.9B
P/E ratio
SummaryFinancials
Period EndRetained earnings (Million USD)YoY (%)
Dec 31, 2024285+135.14%
Dec 31, 2023121+143.22%
Dec 31, 202250-289.52%
Dec 31, 2021-26-51.01%
Dec 31, 2020-54-58.27%
Dec 31, 2019-129-19.85%
Dec 31, 2018-161+26.87%
Dec 31, 2017-127+17.03%
Dec 31, 2016-108+20.06%
Dec 31, 2015-90+28.97%
Dec 31, 2014-70+28.54%
Dec 31, 2013-54+28.82%
Dec 31, 2012-42+10.70%
Dec 31, 2011-38

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)